{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:57:58Z","timestamp":1774465078711,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.carrev.2020.01.012","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T02:18:58Z","timestamp":1579141138000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Charan","family":"Yerasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Forrestal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kolm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.carrev.2020.01.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.carrev.2020.01.012_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2018","journal-title":"Eur Heart J."},{"issue":"7","key":"10.1016\/j.carrev.2020.01.012_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.carrev.2020.01.012_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.carrev.2020.01.012_bb0025","author":"Stiles"},{"issue":"16","key":"10.1016\/j.carrev.2020.01.012_bb0030","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study","volume":"96","author":"Cortese","year":"2010","journal-title":"Heart"},{"issue":"Suppl K","key":"10.1016\/j.carrev.2020.01.012_bb0035","doi-asserted-by":"crossref","first-page":"K83","DOI":"10.4244\/EIJV7SKA15","article-title":"Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus","volume":"7","author":"Ali","year":"2011","journal-title":"EuroIntervention"},{"issue":"25","key":"10.1016\/j.carrev.2020.01.012_bb0040","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.jacc.2012.02.027","volume":"59","author":"Belkacemi","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2020.01.012_bb0045","first-page":"1138","volume":"80","author":"Stella","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10150","key":"10.1016\/j.carrev.2020.01.012_bb0050","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet."},{"issue":"23","key":"10.1016\/j.carrev.2020.01.012_bb0055","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2020.01.012_bb0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ahj.2013.08.023","article-title":"Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial","volume":"166","author":"Liistro","year":"2013","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2020.01.012_bb0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3346\/jkms.2017.32.6.933","article-title":"Comparison of drug-eluting balloon followed by bare metal stent with drug-eluting stent for treatment of de novo lesions: randomized, controlled, single-center clinical trial","volume":"32","author":"Chae","year":"2017","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.carrev.2020.01.012_bb0070","first-page":"323","article-title":"Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent","volume":"84","author":"Clever","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2020.01.012_bb0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/CIRCINTERVENTIONS.113.001146","article-title":"Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up","volume":"7","author":"Poerner","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2020.01.012_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4244\/EIJV10I1A10","article-title":"A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results","volume":"10","author":"Lopez Minguez","year":"2014","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2020.01.012_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2015.01.080","article-title":"A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study","volume":"184","author":"Naganuma","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2020.01.012_bb0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/joic.12210","article-title":"Stenting and adjunctive delivery of paclitaxel via balloon coating versus durable polymeric matrix for de novo coronary lesions: clinical and angiographic results from the prospective randomized trial","volume":"28","author":"Zurakowski","year":"2015","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2020.01.012_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2016.07.156","article-title":"Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease","volume":"222","author":"Nishiyama","year":"2016","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2020.01.012_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.amjms.2017.07.005","article-title":"Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study","volume":"354","author":"Gobic","year":"2017","journal-title":"Am J Med Sci"},{"issue":"17","key":"10.1016\/j.carrev.2020.01.012_bb0105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION Randomized Trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.01.012_bb0110","author":"McKeown"},{"issue":"5","key":"10.1016\/j.carrev.2020.01.012_bb0115","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jcin.2011.03.005","article-title":"Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program","volume":"4","author":"Stone","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"9867","key":"10.1016\/j.carrev.2020.01.012_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.carrev.2020.01.012_bb0125","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2020.01.012_bb0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892030021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892030021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:17:09Z","timestamp":1761560229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383892030021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S155383892030021X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.01.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}